These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37097674)

  • 1. Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer.
    Nakamura M; Ishikawa H; Ohnishi K; Baba K; Sumiya T; Murakami M; Hiroshima Y; Mizumoto M; Okumura T; Sakurai H
    Anticancer Res; 2023 May; 43(5):2003-2013. PubMed ID: 37097674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated proton beam therapy for centrally located lung cancer.
    Nakamura N; Hotta K; Zenda S; Baba H; Kito S; Akita T; Motegi A; Hojo H; Nakamura M; Parshuram RV; Okumura M; Akimoto T
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):552-556. PubMed ID: 31145553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer.
    Nakamura M; Ishikawa H; Ohnishi K; Baba K; Saito T; Sumiya T; Murakami M; Hiroshima Y; Nakai K; Mizumoto M; Okumura T; Sakurai H
    Anticancer Res; 2022 Jun; 42(6):2953-2960. PubMed ID: 35641259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease.
    Saito T; Ohnishi K; Ishikawa H; Nakamura M; Hoshiai S; Numajiri H; Murofushi KN; Mizumoto M; Okumura T; Sakurai H
    Anticancer Res; 2021 Nov; 41(11):5635-5642. PubMed ID: 34732436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
    Kanemoto A; Okumura T; Ishikawa H; Mizumoto M; Oshiro Y; Kurishima K; Homma S; Hashimoto T; Ohkawa A; Numajiri H; Ohno T; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Clin Lung Cancer; 2014 Mar; 15(2):e7-12. PubMed ID: 24365049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
    Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
    Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
    Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer.
    Bayasgalan U; Moon SH; Jeong JH; Kim TH; Cho KH; Suh YG
    Radiat Oncol; 2021 Aug; 16(1):155. PubMed ID: 34407855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
    Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
    Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
    Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated three-dimensional conformal radiation therapy alone for centrally located cT1-3N0 non-small-cell lung cancer.
    Oh D; Ahn YC; Kim B; Pyo H
    J Thorac Oncol; 2013 May; 8(5):624-9. PubMed ID: 23584294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center.
    Bush DA; Cheek G; Zaheer S; Wallen J; Mirshahidi H; Katerelos A; Grove R; Slater JD
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):964-8. PubMed ID: 23845845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
    Volpe S; Piperno G; Colombo F; Biffi A; Comi S; Mastroleo F; Maria Camarda A; Casbarra A; Cattani F; Corrao G; de Marinis F; Spaggiari L; Guckenberger M; Orecchia R; Alterio D; Jereczek-Fossa BA
    Cancer Treat Rev; 2022 Nov; 110():102464. PubMed ID: 36194908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer.
    Kharod SM; Nichols RC; Henderson RH; Morris CG; Pham DC; Seeram VK; Jones LM; Antonio-Miranda M; Huh S; Li Z; Hoppe BS
    Acta Oncol; 2020 Oct; 59(10):1164-1170. PubMed ID: 32394776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer.
    Nakamura M; Ishikawa H; Ohnishi K; Mori Y; Baba K; Nakazawa K; Shiozawa T; Sekine I; Maruo K; Okumura T; Sakurai H
    J Radiat Res; 2023 Mar; 64(2):438-447. PubMed ID: 36592478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer.
    Ono T; Nakamura T; Yamaguchi H; Azami Y; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M; Nemoto K
    Radiat Oncol; 2018 Feb; 13(1):19. PubMed ID: 29402290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.